Imaging features of volume replacement using an acellular dermal matrix in oncoplastic breast conserving surgery: A case report

Lee, Chae Bin; Kim, Young Seon; Lee, Seung Eun

doi:10.1016/j.radcr.2022.03.003

Cited by 4 publications

(5 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On ultrasound, AlloDerm has been described as isoechoic to hypoechoic masses with smooth margins and variable internal color flow [8,10,11]. On MRI, AlloDerm was isointense to glandular tissue on non-contrast fat-saturated T1-weighted images, hyperintense on fat-saturated T2-weighted images, and had variable post-contrast enhancement [7,8,10,12]. This variability is attributed to the different stages and extent of neovascularization and incorporation of the ADM into the host [11].…”

Section: Discussionmentioning

confidence: 99%

Imaging features of acellular dermal matrix in the reconstructed breast after breast cancer

Chandora,

Zalasin,

Woodard

et al. 2023

Clin Case Rep Rev

View full text Add to dashboard Cite

Case 247-year-old female with history of right breast ER+, PR+ DCIS arising in association with a sclerosing papilloma status post bilateral skin-sparing total mastectomy and two-stage reconstruction with placement of ADM and bilateral prepectoral silicone gel implants. Two years after surgery, the patient presented with bilateral palpable findings and underwent targeted ultrasound as well as MRI. Patient subsequently underwent revision of right breast reconstruction (Figure 2).

show abstract

Section: Discussionmentioning

confidence: 99%

Imaging features of acellular dermal matrix in the reconstructed breast after breast cancer

Chandora,

Zalasin,

Woodard

et al. 2023

Clin Case Rep Rev

View full text Add to dashboard Cite

show abstract

“…It does, however, have drawbacks (for example, infection) (93). ADM has so been the subject of investigations to replace the mesh in these operations (Figure 1D) (1,2,21,29,30,33,36,68,(81)(82)(83)(84)(85)(86)(87)(88)(89)(90)(91)(94)(95)(96)(97)(98)(99)(100)(101).…”

Section: Chestmentioning

confidence: 99%

“…In recent years, the use of ADM in extremity reconstructive surgery has increased ( 1 , 10 , 16 , 19 , 26 , 30 , 40 , 46 , 47 , 62 , 73 , 97 , 124 , 139 , 140 , 154 – 158 ). ADM's applications in the extremities include soft tissue and tendon regeneration, heel and nail bed reconstruction, and burn and diabetic wound management ( Figure 1G ) ( 50 ).…”

Section: Extremitiesmentioning

confidence: 99%

“…Tendon repair has been successful with the use of ADM ( 1 , 10 , 16 , 19 , 26 , 30 , 40 , 46 , 47 , 52 , 54 , 62 , 73 , 97 , 124 , 139 , 140 , 154 – 158 , 161 – 163 ). ADM is an ideal scaffold for native cells and is ready to be vascularized by the host ( 40 , 159 ).…”

Section: Extremitiesmentioning

confidence: 99%

“…In lower limb reconstruction, heel reconstruction is one of the most challenging procedures. Many studies have found ADM to be effective in heel reconstruction ( 1 , 10 , 16 , 19 , 20 , 26 , 30 , 40 , 46 , 47 , 52 , 54 , 62 , 73 , 97 , 124 , 139 , 140 , 154 – 158 , 161 ). A case report of heel reconstruction using ADM and skin graft showed optimal gait function recovery and social participation ( 157 ).…”

Section: Extremitiesmentioning

confidence: 99%

See 2 more Smart Citations

Acellular dermal matrix in reconstructive surgery: Applications, benefits, and cost

Mohammadyari

Parvin²,

Khorvash³

et al. 2023

Front. Transplant.

View full text Add to dashboard Cite

Modern tissue engineering has made substantial advancements that have revolutionized plastic surgery. Acellular dermal matrix (ADM) is an example that has gained considerable attention recently. ADM can be made from humans, bovines, or porcine tissues. ADM acts as a scaffold that incorporates into the recipient tissue. It is gradually infiltrated by fibroblasts and vascularized. Fortunately, many techniques have been used to remove cellular and antigenic components from ADM to minimize immune system rejection. ADM is made of collagen, fibronectin, elastin, laminin, glycosaminoglycans, and hyaluronic acid. It is used in critical wounds (e.g., diabetic wounds) to protect soft tissue and accelerate wound healing. It is also used in implant-based breast reconstruction surgery to improve aesthetic outcomes and reduce capsule contracture risk. ADM has also gained attention in abdominal and chest wall defects. Some studies have shown that ADM is associated with less erosion and infection in abdominal hernias than synthetic meshes. However, its higher cost prevents it from being commonly used in hernia repair. Also, using ADM in tendon repair (e.g., Achilles tendon) has been associated with increased stability and reduced rejection rate. Despite its advantages, ADM might result in complications such as hematoma, seroma, necrosis, and infection. Moreover, ADM is expensive, making it an unsuitable option for many patients. Finally, the literature on ADM is insufficient, and more research on the results of ADM usage in surgeries is needed. This article aims to review the literature regarding the application, Benefits, and costs of ADM in reconstructive surgery.

show abstract

Current State of Evidence-Based Long-Term Monitoring Protocols for Breast Plastic Surgery Patients

Ho,

Chichura,

Pederson

et al. 2024

Ann Surg Oncol

View full text Add to dashboard Cite

Background Recommendations for breast surveillance following breast plastic surgery are frequently changing. Establishing guidelines for long-term monitoring protocols may help identify treatable conditions and prevent untoward sequelae. We sought to evaluate the current state of evidence-based long-term monitoring protocols for patients following breast augmentation, reduction, and breast reconstruction. Methods Official guidelines from various American societies and international societies were analyzed for alignment in evidence-based recommendations regarding breast surveillance. Results The most recent US FDA update recommends magnetic resonance imaging or ultrasound starting 5–6 years after surgery and every 2–3 years thereafter. Discrepancies exist among professional societies: the American Society of Plastic Surgeons (ASPS) aligns with the FDA, while the American Society of Breast Surgeons and American College of Radiology (ACR) find no role for imaging for asymptomatic cases. Ultrasound is first-line for any implant concerns, with MRI if necessary. European societies oppose routine breast implant imaging. Breast reduction patients lack unique screening protocols; monitoring aligns with age and cancer risk factors. Following mastectomy and breast reconstruction, most organizations advocate for annual clinical examinations, with more frequent examinations initially. Evidence suggests that physical examination is sufficient to detect local cancer recurrence, with imaging only indicated if there is concern for recurrence. No surveillance imaging is recommended by the American Society of Clinical Oncology, National Comprehensive Cancer Network, or ASPS; however, ACR recommends mammography for autologous reconstruction only. Conclusion Multispecialty and regulatory body alignment may promote provider and patient adherence. Ongoing studies of long-term outcomes are needed to strengthen the level of evidence for monitoring guidelines.

show abstract

Imaging features of volume replacement using an acellular dermal matrix in oncoplastic breast conserving surgery: A case report

Cited by 4 publications

References 11 publications

Imaging features of acellular dermal matrix in the reconstructed breast after breast cancer

Imaging features of acellular dermal matrix in the reconstructed breast after breast cancer

Acellular dermal matrix in reconstructive surgery: Applications, benefits, and cost

Current State of Evidence-Based Long-Term Monitoring Protocols for Breast Plastic Surgery Patients

Contact Info

Product

Resources

About